Beijing Science Sun Pharmaceutical Co Ltd
SZSE:300485
Beijing Science Sun Pharmaceutical Co Ltd
SZSE:300485
Price:
11.26
CNY
-0.44%
Market Closed
Market Cap:
¥5.4B
Relative Value
The Relative Value of one
Beijing Science Sun Pharmaceutical Co Ltd
stock under the Base Case scenario is
6.49
CNY.
Compared to the current market price of 11.26 CNY,
Beijing Science Sun Pharmaceutical Co Ltd
is
Overvalued by 42%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
6.49
CNY
Overvaluation 42%
Multiples Across Competitors
Competitors Multiples
Beijing Science Sun Pharmaceutical Co Ltd Competitors
Beijing Science Sun Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Beijing Science Sun Pharmaceutical Co Ltd
SZSE:300485
|
5.4B CNY | 13.5 | 66.8 | -3 302.3 | -3 302.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
410.4B USD | 6.9 | 175.9 | 17 | 24.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
201.4B USD | 5.5 | 26.2 | 15 | 15 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
191.8B USD | 6.5 | 22.7 | 15.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.7B USD | 10.1 | 30.8 | 23.5 | 24.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD | 5.8 | 18.5 | 14.1 | 16.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR | 14.3 | 33.7 | 57.9 | 59.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
72.9B AUD | 3.3 | 17 | 11.6 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
